CD56 expression in benign and malignant thyroid lesions.
CONCLUSION: CD56 is a potentially good immunohistochemical marker for differentiating papillary thyroid carcinoma from other benign follicular lesions of the thyroid especially in differentiating follicular variant PTC from FA in equivocal cases.
PMID: 30173227 [PubMed - in process]
Source: Malaysian Journal of Pathology - Category: Pathology Tags: Malays J Pathol Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Epithelial Cancer | Malaysia Health | Pathology | Statistics | Study | Thyroid | Thyroid Cancer | Thyroiditis